People · Operator

Neil Wallack

Named in public records as an officer, director or promoter · active 2007–2007 · Other Technology

1
Companies
1
Filings
$20.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Mendel Biotechnology IncOther TechnologySeries A$20.2M$328.6M2007
Operator network

Neil Wallack at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Justin Adams · 4 companies · 1 sharedJustin AdamsMark Lampert · 3 companies · 1 sharedMark LampertNeal Gutterson · 3 companies · 1 sharedNeal GuttersonPeter Davis · 3 companies · 1 sharedPeter DavisSteve Padgette · 2 companies · 1 sharedSteve PadgetteBRIAN J. STASKAWICZ · 1 companies · 1 sharedBRIAN J. STASKAWI…Brian Staskawicz · 1 companies · 1 sharedBrian StaskawiczGreg Ikonen · 1 companies · 1 sharedGreg IkonenGREGORY J. IKONEN · 1 companies · 1 sharedGREGORY J. IKONENJUSTIN J. ADAMS · 1 companies · 1 sharedJUSTIN J. ADAMSMARK J. LAMPERT · 1 companies · 1 sharedMARK J. LAMPERTNEIL J. WALLACK · 1 companies · 1 sharedNEIL J. WALLACKRichard Crowder · 1 companies · 1 sharedRichard CrowderSTEPHEN J. PADGETTE · 1 companies · 1 sharedSTEPHEN J. PADGET…Mendel Biotechnology Inc · $20.2M raisedMendel Biotechnology …Neil WallackNW
Neil Wallack Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Neil Wallack on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Justin Adams14
Neal Gutterson13
Mark Lampert13
Peter Davis13
Steve Padgette12
STEPHEN J. PADGETTE11
MARK J. LAMPERT11
Greg Ikonen11
Richard Crowder11
Brian Staskawicz11
GREGORY J. IKONEN11
NEIL J. WALLACK11
JUSTIN J. ADAMS11
BRIAN J. STASKAWICZ11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.